OPTN - OptiNose Inc
IEX Last Trade
1.05
-0.020 -1.905%
Share volume: 163,503
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.07
-0.02
-1.87%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-10 | 2023-03-07 | 2023-05-11 | 2023-08-10 | 2023-11-09 | 2024-03-07 | 2024-05-14 | |
| Assets | |||||||||
| Total Assets | 122.832 M | 105.270 M | 144.222 M | 114.925 M | 106.068 M | 101.407 M | 107.729 M | 83.707 M | |
| Current Assets | 118.057 M | 100.931 M | 140.484 M | 112.171 M | 103.610 M | 98.620 M | 105.333 M | 81.122 M | |
| Inventories | 10.973 M | 10.415 M | 9.443 M | 8.303 M | 7.732 M | 8.043 M | 8.052 M | 10.315 M | |
| Other Current Assets | 3.054 M | 2.820 M | 2.865 M | 2.961 M | 2.439 M | 2.359 M | 3.671 M | 4.936 M | |
| Short Term Investments | 3.054 M | 2.820 M | 2.865 M | 2.961 M | 2.439 M | 2.359 M | 3.671 M | 4.936 M | |
| Total Receivables | 25.766 M | 26.616 M | 33.932 M | 16.979 M | 22.128 M | 21.373 M | 19.926 M | 14.227 M | |
| Current Cash | 78.264 M | 61.080 M | 94.244 M | 83.928 M | 71.311 M | 66.845 M | 73.684 M | 51.644 M | |
| Total Non-current Assets | 4.775 M | 4.339 M | 3.738 M | 2.754 M | 2.458 M | 2.787 M | 2.396 M | 2.585 M | |
| Property Plant Equipment | 1.063 M | 901.000 K | 795.000 K | 722.000 K | 723.000 K | 882.000 K | 815.000 K | 754.000 K | |
| Other Assets | 3.712 M | 3.438 M | 2.943 M | 2.032 M | 1.735 M | 1.905 M | 1.581 M | 1.831 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 122.832 M | 105.270 M | 144.222 M | 114.925 M | 106.068 M | 101.407 M | 107.729 M | 83.707 M | |
| Total liabilities | 183.615 M | 178.686 M | 200.846 M | 188.710 M | 175.728 M | 179.022 M | 194.335 M | 182.923 M | |
| Total current liabilities | 55.038 M | 177.795 M | 178.730 M | 166.303 M | 164.299 M | 163.981 M | 176.524 M | 32.705 M | |
| Accounts Payable | 9.829 M | 8.403 M | 5.291 M | 6.244 M | 6.482 M | 5.006 M | 3.886 M | 1.912 M | |
| Other liabilities | 1.094 M | 891.000 K | 22.116 M | 22.407 M | 11.429 M | 15.041 M | 17.811 M | 19.565 M | |
| Current long term debt | 0.000 | 128.107 M | 128.575 M | 128.979 M | 129.394 M | 129.813 M | 130.227 M | 0.000 | |
| Long term debt | 127.483 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 130.653 M | |
| Other liabilities | 1.094 M | 891.000 K | 22.116 M | 22.407 M | 11.429 M | 15.041 M | 17.811 M | 19.565 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -60.783 M | -73.416 M | -56.624 M | -73.785 M | -69.660 M | -77.615 M | -86.606 M | -99.216 M | |
| Common stock | 82.740 M | 83.321 M | 95.092 M | 111.774 M | 111.980 M | 112.230 M | 112.336 M | 112.595 M | |
| Retained earnings | -654.791 M | -669.745 M | -684.893 M | -703.740 M | -701.114 M | -710.408 M | -720.376 M | -734.443 M |